Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Symbotic (SYM) Research & Development (2021 - 2025)

Symbotic (SYM) has disclosed Research & Development for 5 consecutive years, with $43.0 million as the latest value for Q4 2025.

  • Quarterly Research & Development fell 0.63% to $43.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $215.4 million through Dec 2025, up 23.39% year-over-year, with the annual reading at $216.0 million for FY2025, 24.53% up from the prior year.
  • Research & Development hit $43.0 million in Q4 2025 for Symbotic, down from $58.7 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $61.5 million in Q1 2025 to a low of $20.9 million in Q3 2021.
  • Historically, Research & Development has averaged $41.7 million across 5 years, with a median of $43.5 million in 2022.
  • Biggest five-year swings in Research & Development: soared 128.72% in 2022 and later decreased 16.94% in 2023.
  • Year by year, Research & Development stood at $22.2 million in 2021, then skyrocketed by 128.72% to $50.7 million in 2022, then dropped by 16.94% to $42.1 million in 2023, then rose by 2.69% to $43.3 million in 2024, then dropped by 0.63% to $43.0 million in 2025.
  • Business Quant data shows Research & Development for SYM at $43.0 million in Q4 2025, $58.7 million in Q3 2025, and $52.1 million in Q2 2025.